Please enable JavaScript.
Coggle requires JavaScript to display documents.
Chapter 4 Findings (MAH (National, MR-DCP, Central), Pharmacovigilance…
Chapter 4 Findings
MAH
National
MR-DCP
Central
Pharmacovigilance
QPPV
PMSF
Cost
Variations
Outsourced activities
Supply Chain
Availability
Batch release and control
Labelling
Clinical trials
Variations
RMS
Enteral products
Unlicensced speacials
EMA/CmDH
The future after Brexit
MHRA
HPRA